Literature DB >> 17678614

The inhibition of glyceraldehyde-3-phosphate dehydrogenase by nitroxyl (HNO).

Brenda E Lopez1, David A Wink, Jon M Fukuto.   

Abstract

Nitroxyl (HNO) has received recent and significant interest due to its novel and potentially important pharmacology. However, the chemical/biochemical mechanism(s) responsible for its biological activity remain to be established. Some of the most important biological targets for HNO are thiols and thiol proteins. Consistent with this, it was recently reported that HNO inhibits the glycolytic enzyme glyceraldehyde-3-phosphate dehydrogenase (GAPDH), a protein with a catalytically important cysteine thiol at its active site. Interestingly, it was reported that intracellular GAPDH inhibition occurred without significantly altering the cellular thiol redox status of glutathione. Herein, the nature of this reaction specificity was examined. HNO is found to irreversibly inhibit GAPDH in a manner that can be protected against by one of its substrates, glyceraldehyde-3-phosphate (G-3-P). These results are consistent with the idea that HNO has the ability to react with and oxidize a variety of intracellular thiols and the ease or facility of cellular re-reduction of the thiol targets can determine the target specificity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17678614     DOI: 10.1016/j.abb.2007.06.017

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  22 in total

Review 1.  The emergence of nitroxyl (HNO) as a pharmacological agent.

Authors:  Christopher H Switzer; Wilmarie Flores-Santana; Daniele Mancardi; Sonia Donzelli; Debashree Basudhar; Lisa A Ridnour; Katrina M Miranda; Jon M Fukuto; Nazareno Paolocci; David A Wink
Journal:  Biochim Biophys Acta       Date:  2009-05-06

Review 2.  The specificity of nitroxyl chemistry is unique among nitrogen oxides in biological systems.

Authors:  Wilmarie Flores-Santana; Debra J Salmon; Sonia Donzelli; Christopher H Switzer; Debashree Basudhar; Lisa Ridnour; Robert Cheng; Sharon A Glynn; Nazareno Paolocci; Jon M Fukuto; Katrina M Miranda; David A Wink
Journal:  Antioxid Redox Signal       Date:  2011-03-16       Impact factor: 8.401

3.  The antihypertensive effect of cysteine.

Authors:  Sudesh Vasdev; Pawan Singal; Vicki Gill
Journal:  Int J Angiol       Date:  2009

4.  Analysis of the HNO and NO donating properties of alicyclic amine diazeniumdiolates.

Authors:  Gaurav Bharadwaj; Patricia G Z Benini; Debashree Basudhar; Cyf N Ramos-Colon; Gail M Johnson; Marti M Larriva; Larry K Keefer; Daniela Andrei; Katrina M Miranda
Journal:  Nitric Oxide       Date:  2014-09-02       Impact factor: 4.427

Review 5.  Playing with cardiac "redox switches": the "HNO way" to modulate cardiac function.

Authors:  Carlo G Tocchetti; Brian A Stanley; Christopher I Murray; Vidhya Sivakumaran; Sonia Donzelli; Daniele Mancardi; Pasquale Pagliaro; Wei Dong Gao; Jennifer van Eyk; David A Kass; David A Wink; Nazareno Paolocci
Journal:  Antioxid Redox Signal       Date:  2011-03-03       Impact factor: 8.401

6.  Nitroxyl (HNO) acutely activates the glucose uptake activity of GLUT1.

Authors:  Matthew J Salie; Daniel S Oram; David P Kuipers; Jared P Scripture; Jude Chenge; Griffin J MacDonald; Larry L Louters
Journal:  Biochimie       Date:  2011-12-11       Impact factor: 4.079

7.  Aorta from angiotensin II hypertensive mice exhibit preserved nitroxyl anion mediated relaxation responses.

Authors:  Brandi M Wynne; Hicham Labazi; Rita C Tostes; R Clinton Webb
Journal:  Pharmacol Res       Date:  2011-07-08       Impact factor: 7.658

Review 8.  Anticancer agents that counteract tumor glycolysis.

Authors:  Carlotta Granchi; Filippo Minutolo
Journal:  ChemMedChem       Date:  2012-06-08       Impact factor: 3.466

9.  Hydroxylamine acutely activates glucose uptake in L929 fibroblast cells.

Authors:  Larry L Louters; Jared P Scripture; David P Kuipers; Stephen M Gunnink; Benjamin D Kuiper; Ola D Alabi
Journal:  Biochimie       Date:  2012-11-27       Impact factor: 4.079

10.  New acyloxy nitroso compounds with improved water solubility and nitroxyl (HNO) release kinetics and inhibitors of platelet aggregation.

Authors:  Heba A H Mohamed; Mohamed Abdel-Aziz; Gamal El-Din A A Abuo-Rahma; S Bruce King
Journal:  Bioorg Med Chem       Date:  2015-04-16       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.